Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Recruiting 2Active not recruiting 2Suspended 1Completed 1

Sponsor Class

INDUSTRY 3OTHER 2NIH 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

CNS 3Classical hematology 1

Conditions

Breast Neoplasms 1236Neoplasms 1040Carcinoma, Non-Small-Cell Lung 861Prostatic Neoplasms 692Colorectal Neoplasms 614Lung Neoplasms 578Neoplasm Metastasis 439Multiple Myeloma 425Leukemia, Myeloid, Acute 401Pancreatic Neoplasms 376Ovarian Neoplasms 364Melanoma 320Carcinoma, Hepatocellular 288Recurrence 276Squamous Cell Carcinoma of Head and Neck 275Brain Neoplasms 266Glioblastoma 247Head and Neck Neoplasms 244Stomach Neoplasms 239Carcinoma, Renal Cell 228Precursor Cell Lymphoblastic Leukemia-Lymphoma 227Lymphoma 225Triple Negative Breast Neoplasms 219Hematologic Neoplasms 209Endometrial Neoplasms 209Urinary Bladder Neoplasms 202Lymphoma, Non-Hodgkin 197Uterine Cervical Neoplasms 194Sarcoma 190Glioma 190

Interventions

Cannabidiol 2Solutions 1Levetiracetam 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Seizures × 90 days × Clear all
NCT05485831 2026-06-03

EpiTALY

Jazz Pharmaceuticals

Active not recruiting
111 enrolled

Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT02639325 2026-05-29

Tumor Related Epilepsy

National Institutes of Health Clinical Center (CC)

Recruiting
100 enrolled
CNS

Brain Neoplasms, Epilepsy, Neoplasms, Seizures

NCT05864846 2026-04-27

EpiCom

Jazz Pharmaceuticals

Phase 4 Completed
79 enrolled

Behavior, Seizures, Tuberous Sclerosis

NCT06129760 2026-04-08

Glioblastoma Remote Monitoring and Care - Research Protocol

Case Comprehensive Cancer Center

Phase NA Suspended
25 enrolled
CNSClassical hematology

Glioblastoma, Seizures, Venous Thromboembolism

NCT02962414 2026-04-02

Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

Novartis

Phase 3 Active not recruiting
206 enrolled

Seizures, Tuberous Sclerosis

NCT07130786 2026-03-19

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Brigham and Women's Hospital

Phase 2 Recruiting
150 enrolled
CNS

Brain Neoplasms, Necrosis, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡